首页> 外国专利> Convergence system that sterilizes influenza virus and novel virus by applying it to the nasal cavity of the infected nose and sterilizes rhinitis bacteria

Convergence system that sterilizes influenza virus and novel virus by applying it to the nasal cavity of the infected nose and sterilizes rhinitis bacteria

机译:通过将流感病毒和新病毒施加到感染鼻子的鼻腔和灭菌鼻炎细菌的鼻腔消毒的收敛系统

摘要

The present invention is a fusion system that sterilizes influenza virus and novel virus by applying to the nasal cavity of an infected nose and sterilizes rhinitis bacteria, Hydrogen peroxide is mixed with distilled water, purified water, and purified water to produce less than 1% hydrogen peroxide and applied to the nasal cavity of the infected nose or sprayed. The supersaturated oxygen component of hydrogen peroxide water oxidizes components such as genetic factor protein (2) and lipid (3) in the body (1) of influenza virus and novel virus to stop influenza virus and novel virus mutation function and sterilize at the same time. It is characterized by a fusion complex system that sterilizes rhinitis bacteria infected in the nasal passages. In addition, it oxidizes runny nose and organic matter mixed with inorganic substances such as iron and copper, pollen, and fine dust, which are allergens introduced into the nasal passages of the infected nose, and oxidizes them with less than 1% hydrogen peroxide. Oxidized hydrogen peroxide water of less than 1% generates water and oxygen to prevent rhinitis in an environment-friendly way and is characterized by a fusion system that sterilizes rhinitis bacteria. In addition, when two or more of rapidly mutating viruses such as Ebola virus, Zika virus, avian flu, MERS virus, influenza virus, coronavirus, zoonotic disease, etc. are mixed or infected with a new strain of virus Regardless of the type of virus introduced into the nasal cavity (4) of the nose without wasting time for diagnosis, prevention and treatment It is characterized in that it rapidly and excellently removes viruses by contact oxidation with less than 1% hydrogen peroxide. It is a fusion system that sterilizes influenza virus and new virus by applying it to the nasal cavity of the infected nose and sterilizes rhinitis bacteria. In addition, in the process of sterilization and sterilization, the virus is sterilized and sterilized by contact oxidation of the virus with the supersaturated oxygen component of less than 1% hydrogen peroxide. It is characterized by a convergence system that generates and treats the virus that survives and has decreased in function by easily attacking and killing the virus with the body's immune system, while generating antibodies excellently to create a vaccine effect. It is a fusion system that sterilizes influenza virus and new virus by applying it to the nasal cavity of the infected nose and sterilizes rhinitis bacteria. In addition, the medicine of the present invention, which is applied or sprayed to the nasal cavity (4), which is the respiratory tract of the human body, and electrodeposited on the mucous membrane of the nasal hairs (5) of the nostrils, rides the mucus of the nasal cavity (4), which is the respiratory tract, and the medicine is directed toward the bronchi and lungs (6). It is characterized by excellent treatment of the human body by sterilizing bacteria and viruses introduced into the bronchi and lungs (6) by flowing and moving. It is a fusion system that sterilizes influenza virus and new virus by applying it to the nasal cavity of the infected nose and sterilizes rhinitis bacteria. In addition, supersaturated oxygen of less than 1% hydrogen peroxide solution is applied or sprayed to the nasal cavity (4), which is the respiratory tract of the human body, characterized in that it decomposes and removes dead cells in the nasal cavity (4). It is a fusion system that sterilizes influenza virus and new virus by applying it to the nasal cavity of the infected nose and sterilizes rhinitis bacteria. [Index] Convergence system that sterilizes influenza virus and new virus and sterilizes rhinitis bacteria by applying it to the nasal cavity of the infected nose, Oxidized hydrogen peroxide water of less than 1% generates water and oxygen to prevent rhinitis in an environment-friendly way, sterilizes rhinitis bacteria, Removes viruses quickly and excellently by contact oxidation with less than 1% hydrogen peroxide. It sterilizes and sterilizes by contacting and oxidizing the virus to the supersaturated oxygen component of less than 1% hydrogen peroxide solution. A convergence system that creates a vaccine effect and treats a virus that survives and loses its function by easily attacking and killing the virus with the body's immune system. Apply or spray supersaturated oxygen of less than 1% hydrogen peroxide solution to the respiratory tract (4) of the human body to decompose and remove dead cells in the respiratory tract (4).
机译:本发明是一种融合系统,它通过施加到感染的鼻子的鼻腔和灭菌鼻炎细菌的鼻腔来消毒流感病毒和新病毒,将过氧化氢与蒸馏水,纯净水和纯净的水混合,以产生小于1%的氢气过氧化物并施用于感染鼻子的鼻腔或喷涂。过氧化氢水的过饱和氧组分在流感病毒和新型病毒的体(1)中氧化诸如遗传因子蛋白(2)和脂质(3)的组分,以阻止流感病毒和新型病毒突变功能并同时灭菌。它的特征在于一种融合复杂系统,可灭菌感染在鼻腔通道中的鼻炎细菌。此外,它氧化流鼻涕和有机物质,与无机物质如铁和铜,花粉和细粉尘,它们是引入感染鼻子的鼻腔通道的过敏原,并用少于1%的过氧化氢氧化它们。氧化过氧化氢水分小于1%的水产生水和氧气,以防止鼻炎以环保方式,其特征在于灭菌鼻炎细菌的融合系统。此外,当两种或更多种快速突变的病毒如埃博拉病毒,Zika病毒,禽流感,MERS病毒,流感病毒,冠状病毒,人畜共患病等,无论是一种新的病毒都是一种新的病毒将病毒引入鼻腔(4)的鼻腔(4)而不浪费诊断,预防和治疗的特征在于,它通过少于1%过氧化氢的接触氧化迅速和优异地除去病毒。它是一种融合系统,可以通过将流感病毒和新病毒施加到感染的鼻子的鼻腔和灭菌鼻炎细菌来消毒流感病毒和新病毒。此外,在灭菌和灭菌的过程中,病毒通过与过氧化氢的过饱和氧组分接触氧化而通过与病毒的氧化氧化进行灭菌和灭菌。它的特征在于收敛系统,产生和治疗病毒,通过易于攻击和杀死身体的免疫系统,同时产生抗体以产生疫苗效果的同时产生和杀死病毒的功能。它是一种融合系统,可以通过将流感病毒和新病毒施加到感染的鼻子的鼻腔和灭菌鼻炎细菌来消毒流感病毒和新病毒。此外,本发明的药物,其被施用或喷洒到鼻腔(4),该鼻腔(4)是人体的呼吸道,并且在鼻孔(5)的粘膜上电沉积在鼻孔(5)上,骑行鼻腔(4)的粘液,即呼吸道,药物朝向支气管和肺部(6)。其特征在于通过流动和移动通过灭菌和肺部(6)引入支气管和肺部(6)的灭菌和病毒来优异地治疗人体。它是一种融合系统,可以通过将流感病毒和新病毒施加到感染的鼻子的鼻腔和灭菌鼻炎细菌来消毒流感病毒和新病毒。此外,将过氧化氢溶液的超饱和氧施用或喷洒到鼻腔(4),其是人体的呼吸道,其特征在于它分解并除去鼻腔中的死细胞(4 )。它是一种融合系统,可以通过将流感病毒和新病毒施加到感染的鼻子的鼻腔和灭菌鼻炎细菌来消毒流感病毒和新病毒。 [指数]通过将流感病毒和新病毒灭菌和灭菌鼻窦炎灭菌的收敛系统通过将鼻腔施加到感染鼻的鼻腔,氧化过氧化氢水分小于1%,产生水和氧气,以防止鼻炎以环绕的方式,灭菌鼻炎细菌,通过含有小于1%的过氧化氢,通过接触氧化快速,快速地除去病毒。通过使病毒与过氧化氢溶液的少于1%的氧化溶液接触和氧化病毒来灭菌和灭菌。一种收敛系统,产生疫苗效应并治疗病毒,通过易于攻击和杀死身体的免疫系统来攻击和杀死病毒。将过氧化氢溶液的过饱和氧涂抹或喷雾过氧化氢溶液,以将呼吸道(4)的呼吸道(4)分解并去除呼吸道中的死细胞(4)。

著录项

  • 公开/公告号KR20210125875A

    专利类型

  • 公开/公告日2021-10-19

    原文格式PDF

  • 申请/专利权人 이 석 규;이광석;

    申请/专利号KR1020200044214

  • 发明设计人 이 석 규;이광석;

    申请日2020-04-09

  • 分类号A61K33/40;A61K9;A61P31/12;A61P31/14;A61P31/16;

  • 国家 KR

  • 入库时间 2024-06-14 22:14:49

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号